Successful scientists under 30

EVERY year brings milestones in technology, science and health. What were once seen as obstacles in the path of human progress are now insignificant to those at the head of change.

The fields of medicine and health sciences are advancing at a rapid pace, finding solutions to problems once considered unfathomable.

Let’s have a look at some of the young and successful minds under 30 years old that are behind these modern breakthroughs.

Students of CeMBA can look forward to greater opportunities for enhanced responsibilities and promotions in their job and career upon the completion of study.

Rohan Suri, 18, founder of Averia Health Solutions

A bright mind, Suri is the founder of Averia Health Solutions, through which he developed an improved concussion test at the young age of 17.

Using the increased popularity of eye-tracking tests to diagnose concussions and his own brother’s misdiagnosed concussion as inspiration, Suri created an app and special headset to diagnose concussions from a smartphone.

Together, the modified headset and app record and analyse eye movement to diagnose the severity or improvement of an injury within a minute.

Averia’s key innovation is to make expensive equipment easily accessible to sporting youth, who are at the greatest risks of suffering misdiagnosed concussions.

Jessie Becker, 27, co-founder of InPress Technologies

Becker is an innovator in the healthcare field as well as co-founder and chief executive officer of InPress Technologies.

Her company is committed to the development of a device that stops maternal death caused by heavy bleeding after childbirth, called postpartum haemorrhage (PPH). PPH is the leading cause of death among mothers.

With its efficient simplicity, the device has great potential to save the lives of women all over the world.

Alice Zhang, 28, co-founder of Verge Genomics

After the shocking discovery that 90% of medicines starting human studies fail, 28-year-old Zhang was inspired to co-found her start-up company Verge Genomics – the latest of its kind in a long line of biotechnological companies.

Verge uses new technologies for decoding human DNA to come up with drug-based solutions to Alzheimer’s and Parkinson’s disease, an area many pharmaceutical companies have given up on.

Alexander Bisignano, 29, co-founder of Recombine

In his pursuit of building products for the improvement of healthcare diagnostics delivery, 29-year-old Bisignano is the founding chief executive of Recombine.

Through an understanding of the human genome, this genetics testing company tests couples to predict and screen for potential diseases that may be passed on to their children.

Bisignano is set to make further